Since 1970 until recently, over 20 experiments have been conducted by a large drug manufacturer proving that lemon and other citrus fruits have the power to destroy cancerous cells and are 10,000 times stronger than drugs like Adriamycin.
Lemon has strong antimicrobial and anti–carcinogenic properties which can even cure tumors. Lemons prevent fungal infections, regulate blood pressure and reduce the effects of depression and stress. Lemon also calms the nervous system. We add baking soda to lemon because it normalizes the pH of the body which prevents cancer from further spreading.
Lemon and baking soda combination is effective in preventing 12 types of cancers including throat cancer, lung cancer, and colon cancer. Chemotherapy and radiation do destroy cancer cells but also kill healthy cells, making the body very weak. Lemon and baking soda kill only the cancerous cells while keeping the healthy cells intact. Just make sure to use organic lemon as it is 100 times more effective.
Research conducted in this area
1.Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells
“Lemons are a widely used citrus crop and have shown several potential health benefits. In the present study, the mechanism and effectiveness of the anti-cancer and anti-aromatase properties of limonoids were investigated for the first time. Defatted lemon (Citrus lemon L. Burm) seed powder was extracted with ethyl acetate (EtOAc) and methanol (MeOH) for 16 h each, successively. Our findings indicated that the citrus limonoids may have potential for the prevention of estrogen- responsive breast cancer (MCF-7) via caspase-7 dependent pathways.”
2.Citrus fruit and cancer risk in a network of case-control studies
“Citrus fruit has shown a favorable effect against various cancers. The studies included 955 patients with oral and pharyngeal cancer, 395 with esophageal, 999 with stomach, 3,634 with large bowel, 527 with laryngeal, 2,900 with breast, 454 with endometrial, 1,031 with ovarian, 1,294 with prostate, and 767 with renal cell cancer. The ORs for the highest versus lowest category of citrus fruit consumption were 0.47 (95% confidence interval, CI, 0.36-0.61) for oral and pharyngeal, 0.42 (95% CI, 0.25-0.70) for esophageal, 0.69 (95% CI, 0.52-0.92) for stomach, 0.82 (95% CI, 0.72-0.93) for colorectal, and 0.55 (95% CI, 0.37-0.83) for laryngeal cancer. No consistent association was found with breast, endometrial, ovarian, prostate, and renal cell cancer. Our findings indicate that citrus fruit has a protective role against cancers of the digestive and upper respiratory tract.”
3.Citrus limonoids: analysis, bioactivity, and biomedical prospects
Limonoids are a prominent group of secondary metabolites in citrus fruit. The bitter character of some compounds in this group has historically compromised the quality of citrus fruit and juice. Detecting bitter limonoids in citrus, understanding their origins, and developing methods for their removal from citrus juices have provided the basis for citrus limonoid research. Evaluation of the biological activity of citrus limonoids has indicated the potential of these compounds to improve human health as anticancer, cholesterol-lowering, and antiviral agents. This review chronicles the evolution of citrus limonoid research from defining their participation in citrus bitterness to their potential utilization as important contributors to improving human health and well-being.
Source of research studies: http://pubs.rsc .org/en/content/articlelanding/2013/fo/c2fo30209h#!divAbstract
Comments